Holen Sie sich die Stockscreener-App
0.9515
9.66%
0.0838
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.8677
Offen:
$0.87
24-Stunden-Volumen:
81.08M
Relative Volume:
2.00
Marktkapitalisierung:
$888.67M
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-3.1717
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
+2.00%
1M Leistung:
-18.68%
6M Leistung:
-49.66%
1J Leistung:
-46.54%
1-Tages-Spanne:
$0.8251
$1.03
1-Wochen-Bereich:
$0.8251
$1.03
52-Wochen-Spanne:
$0.8251
$2.97
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Vergleichen Sie TLRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.9515 | 888.67M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Eingeleitet | Barclays | Underweight |
| 2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Fortgesetzt | Cowen | Outperform |
| 2021-05-07 | Fortgesetzt | Jefferies | Buy |
| 2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-01 | Bestätigt | MKM Partners | Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-05-12 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-11-13 | Bestätigt | The Benchmark Company | Buy |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Eingeleitet | Oppenheimer | Perform |
| 2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Tilray (TLRY): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors - Yahoo Finance
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs - GlobeNewswire
Delaware court frees former Tilray partners from $13M Marley licensing fee - Green Market Report
12 Best Get Rich Fast Stocks To Buy Now - Insider Monkey
Is Tilray Brands, Inc. (TLRY) the Best Get Rich Fast Stock to Buy Now? - Insider Monkey
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs -February 20, 2025 at 08:03 am EST - Marketscreener.com
Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
Tilray Brands, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know - MSN
Tilray Brands Inc. stock falls Tuesday, underperforms market - MarketWatch
Looking Into Tilray Brands's Recent Short Interest - Benzinga
Tilray stock touches 52-week low at $0.9 amid market challenges - Investing.com India
Decibel Expands General Admission Brand's International Footprint - Cannabis Business Times
HYTN, A1 Cannabis Partner to Scale Production of Cannabis Products - Cannabis Business Times
Tilray stock price crashes below $1: buy the dip or sell the rip? - MSN
Tilray (NASDAQ:TLRY) Trading Down 0.1%What's Next? - MarketBeat
Top Cannabis Stocks To Watch TodayFebruary 17th - MarketBeat
Tilray (NASDAQ:TLRY) Trading Down 1.1%Should You Sell? - MarketBeat
Tilray (NASDAQ:TLRY) Shares Down 3.7%Here's Why - MarketBeat
Tilray: Improved Balance Sheet And Reasonable Valuation (Rating Upgrade) - Seeking Alpha
Tilray (NASDAQ:TLRY) Stock Price Down 0.5%What's Next? - MarketBeat
2 Beaten-Down Stocks to Avoid - MSN
Tilray (NASDAQ:TLRY) Stock Price Down 0.1%Here's What Happened - MarketBeat
Best Cannabis Stocks To Follow TodayFebruary 15th - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 3.7%What's Next? - MarketBeat
Top Cannabis Stocks To ConsiderFebruary 13th - MarketBeat
Tilray Brands Inc. stock falls Friday, underperforms market - MarketWatch
Tilray (NASDAQ:TLRY) Trading Down 4%What's Next? - MarketBeat
Best Cannabis Stocks To ConsiderFebruary 14th - MarketBeat
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note - MSN
Cannabis Stocks To ResearchFebruary 12th - MarketBeat
StockTalk | Cannabis Report: Vapes, ketamine, and celebrity endorsements | 2025-02-14 | Investing News - Stockhouse Publishing
Tilray (NASDAQ:TLRY) Trading Down 5.2%Time to Sell? - MarketBeat
Tilray Brands Inc. stock rises Wednesday, outperforms market - MarketWatch
Tilray Ceases Large-Scale Production at Revolver; Taproom Remains Open - Brewbound.com
Tilray Medical Expands Medical Cannabis Portfolio in Germany -February 11, 2025 at 07:00 am EST - Marketscreener.com
Beyond Germany: Other international markets for cannabis opportunities - Green Market Report
Tilray élargit son portefeuille de produits à base de cannabis thérapeutique en Allemagne - GlobeNewswire Inc.
Tilray stock touches 52-week low at $0.94 amid market challenges - MSN
Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival - Tilray
Tilray stock touches 52-week low at $0.94 amid market challenges By Investing.com - Investing.com South Africa
Tilray expands German medical cannabis offering | 2025-02-11 | Investing News - Stockhouse Publishing
Ultimate Summer Festival Alert: Blue Point's Shakedown Combines Craft Beer, Live Music & Local Art - StockTitan
Tilray Brief: Launching New Cannabis Extract Products And Formulations As Expands Medical Cannabis Portfolio in Germany - Marketscreener.com
Tilray Brief: Expanding Medical Cannabis Portfolio in Germany -February 11, 2025 at 07:14 am EST - Marketscreener.com
Tilray Expands Medical Cannabis Portfolio in Germany - The Manila Times
Tilray (TLRY) Launches Game-Changing THC-CBD Extracts in Europe's Largest Market - StockTitan
Cannabis Cultivation Market Is Booming Worldwide 2025-2032:Aphria, Inc, Aurora Cannabis, Tilray, Organigram - EIN News
International cannabis markets could offer better growth opportunities - Green Market Report
Tilray (TLRY) Stock Drops 5% Amidst Market Fluctuations - GuruFocus.com
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tilray Brands Inc-Aktie (TLRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
3.23%
3.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):